Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CMGC family protein kinase | 0.2687 | 0.251 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.2687 | 0.251 | 0.2359 |
Echinococcus granulosus | propionyl coenzyme A carboxylase beta chain | 0.1141 | 0.0532 | 0.0236 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.3206 | 0.3174 | 0.5531 |
Loa Loa (eye worm) | hypothetical protein | 0.758 | 0.877 | 0.9051 |
Wolbachia endosymbiont of Brugia malayi | Acetyl/propionyl-CoA carboxylase, alpha subunit | 0.3206 | 0.3174 | 1 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain, AccA2 | 0.3206 | 0.3174 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.2687 | 0.251 | 0.2551 |
Leishmania major | carboxylase, putative | 0.3206 | 0.3174 | 0.3226 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.2687 | 0.251 | 0.4375 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.2687 | 0.251 | 0.2276 |
Mycobacterium ulcerans | bifunctional protein acetyl-/propionyl-coenzyme a carboxylase (alpha chain) AccA3 | 0.3206 | 0.3174 | 1 |
Leishmania major | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.1141 | 0.0532 | 0.0541 |
Echinococcus granulosus | propionyl coenzyme A carboxylase alpha chain | 0.3206 | 0.3174 | 0.2961 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.2687 | 0.251 | 0.2551 |
Schistosoma mansoni | cgmp-dependent 35-cyclic phosphodiesterase | 0.0962 | 0.0303 | 0.0308 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.3206 | 0.3174 | 0.3226 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase beta chain | 0.1141 | 0.0532 | 0.0236 |
Mycobacterium ulcerans | propionyl-CoA carboxylase beta chain 5 AccD5 | 0.1141 | 0.0532 | 0.1676 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.2687 | 0.251 | 0.2551 |
Mycobacterium ulcerans | acetyl-/propionyl-CoA carboxylase subunit beta | 0.1141 | 0.0532 | 0.1676 |
Plasmodium vivax | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.6091 | 0.6864 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.2687 | 0.251 | 0.4375 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.3206 | 0.3174 | 0.3226 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.2687 | 0.251 | 0.4375 |
Trypanosoma cruzi | acetyl-CoA carboxylase | 0.5211 | 0.5739 | 1 |
Trypanosoma cruzi | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.1141 | 0.0532 | 0.0927 |
Mycobacterium ulcerans | acetyl-coenzyme a carboxylase carboxyl transferase (subunit beta) AccD3 | 0.1141 | 0.0532 | 0.1676 |
Schistosoma mansoni | pyruvate carboxylase | 0.3206 | 0.3174 | 0.3226 |
Plasmodium falciparum | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.6091 | 0.6864 | 1 |
Trypanosoma cruzi | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.1141 | 0.0532 | 0.0927 |
Brugia malayi | Carboxyl transferase domain containing protein | 0.8122 | 0.9463 | 0.9446 |
Leishmania major | acetyl-CoA carboxylase, putative | 0.8416 | 0.984 | 1 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain AccA1 | 0.3206 | 0.3174 | 1 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0962 | 0.0303 | 0.0308 |
Loa Loa (eye worm) | hypothetical protein | 0.8274 | 0.9657 | 1 |
Mycobacterium tuberculosis | Probable acetyl-/propionyl-coenzyme A carboxylase alpha chain (alpha subunit) AccA2: biotin carboxylase + biotin carboxyl carrie | 0.3206 | 0.3174 | 1 |
Echinococcus granulosus | macrophage colony stimulating factor 1 receptor | 0.2161 | 0.1838 | 0.1582 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2687 | 0.251 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2687 | 0.251 | 1 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0962 | 0.0303 | 0.0529 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0962 | 0.0303 | 0.0529 |
Trypanosoma brucei | 3-methylcrotonoyl-CoA carboxylase beta subunit, putative | 0.1141 | 0.0532 | 0.0541 |
Toxoplasma gondii | acetyl-coA carboxylase ACC2 | 0.8416 | 0.984 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.2687 | 0.251 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.2687 | 0.251 | 0.2551 |
Brugia malayi | MAP kinase sur-1 | 0.2687 | 0.251 | 0.2276 |
Chlamydia trachomatis | biotin carboxylase | 0.2911 | 0.2797 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.2687 | 0.251 | 0.2276 |
Trypanosoma brucei | unspecified product | 0.2108 | 0.1769 | 0.1798 |
Echinococcus granulosus | mitogen activated protein kinase | 0.2687 | 0.251 | 0.2276 |
Echinococcus multilocularis | cAMP and cAMP inhibited cGMP 3',5' cyclic | 0.8542 | 1 | 1 |
Mycobacterium ulcerans | propionyl-CoA carboxylase beta chain 4 AccD4 | 0.1141 | 0.0532 | 0.1676 |
Mycobacterium leprae | Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase, alpha chain AccA3 (BccP) | 0.3206 | 0.3174 | 1 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.3206 | 0.3174 | 0.3226 |
Trypanosoma cruzi | cAMP specific phosphodiesterase, putative | 0.0962 | 0.0303 | 0.0529 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase alpha chain | 0.3206 | 0.3174 | 0.2961 |
Mycobacterium ulcerans | pyruvate carboxylase | 0.3206 | 0.3174 | 1 |
Wolbachia endosymbiont of Brugia malayi | Acetyl-CoA carboxylase, carboxyltransferase component | 0.1141 | 0.0532 | 0.1676 |
Toxoplasma gondii | acyl-CoA carboxyltransferase beta chain, putative | 0.1141 | 0.0532 | 0.0541 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.3607 | 0.3688 | 0.3748 |
Mycobacterium ulcerans | propionyl-CoA carboxylase beta chain 4 AccD4_2 | 0.1141 | 0.0532 | 0.1676 |
Echinococcus granulosus | cAMP and cAMP inhibited cGMP 3'5' cyclic | 0.8542 | 1 | 1 |
Trypanosoma brucei | cAMP-specific phosphodiesterase | 0.0962 | 0.0303 | 0.0308 |
Schistosoma mansoni | propionyl-CoA carboxylase beta chain mitochondrial precursor | 0.1141 | 0.0532 | 0.0541 |
Leishmania major | methylcrotonoyl-coa carboxylase biotinylated subunitprotein-like protein | 0.3206 | 0.3174 | 0.3226 |
Trypanosoma brucei | protein kinase, putative | 0.2687 | 0.251 | 0.2551 |
Mycobacterium tuberculosis | Probable pyruvate carboxylase Pca (pyruvic carboxylase) | 0.3206 | 0.3174 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2687 | 0.251 | 1 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.3206 | 0.3174 | 0.5531 |
Schistosoma mansoni | camp/cgmp cyclic nucleotide phosphodiesterase | 0.0962 | 0.0303 | 0.0308 |
Mycobacterium ulcerans | acetyl/propionyl CoA carboxylase subunit beta | 0.1141 | 0.0532 | 0.1676 |
Trypanosoma cruzi | acetyl-CoA carboxylase, putative | 0.1141 | 0.0532 | 0.0927 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.2687 | 0.251 | 0.4375 |
Entamoeba histolytica | acetyl-coA carboxylase, putative | 0.1435 | 0.0909 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.2687 | 0.251 | 0.2276 |
Loa Loa (eye worm) | carboxyl transferase domain-containing protein | 0.8122 | 0.9463 | 0.9792 |
Leishmania major | propionyl-coa carboxylase beta chain, putative | 0.1141 | 0.0532 | 0.0541 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.3206 | 0.3174 | 0.3226 |
Toxoplasma gondii | pyruvate carboxylase | 0.3206 | 0.3174 | 0.3226 |
Echinococcus multilocularis | acetyl coenzyme A carboxylase 1 | 0.8416 | 0.984 | 0.9835 |
Schistosoma mansoni | acetyl-CoA carboxylase | 0.8416 | 0.984 | 1 |
Toxoplasma gondii | acetyl-CoA carboxylase ACC1 | 0.8416 | 0.984 | 1 |
Echinococcus granulosus | acetyl coenzyme A carboxylase 1 | 0.8416 | 0.984 | 0.9835 |
Trypanosoma brucei | acetyl-CoA carboxylase | 0.8416 | 0.984 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.2687 | 0.251 | 0.2551 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.